A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Online
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.
Thriving Commerce on Social Networks
Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Voice Concerns
However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could result in users administering products of unknown origin.
Several professionals said the popularity for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.
Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.
Platform Reaction and Content Elimination
According to the social media company, the platform has taken down problematic material and banned related keywords and search suggestions. The company stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Trading Activities
Research also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, filled with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at home.
Within minutes of joining one community, a vendor shared WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Item Information and Costs
Inside these groups, messages display black plastic parcels with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it actively moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to potentially serious medical dangers”.
